The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease

Enrolling by invitation

Conditions studied: COPD, COPD Exacerbation Acute, Comorbid Chronic Lung Disease on Heart Failure, Mortality, Cardiovascular Diseases, Cardiovascular Events, COPD Prevalance

In brief

Chronic obstructive pulmonary disease (COPD) is a treatable but debilitating medical condition associated with persistent symptoms and chronic airflow obstruction. Despite the availability of multiple therapeutic options, COPD is the third leading cause of death worldwide and has a substantial socioeconomic impact. The present real life study is aimed at describing the clinical and functional characteristics, treatment patterns, impact of exacerbations and comorbidities and their association with mortality in a large cohort of Italian patients with COPD.

Key facts

Study ID

NCT06652776

Run by

University of Milan

People needed

10000

Starts

2024-09-30

Expected to finish

2035-12-31

Last updated by the study team

2026-05-04

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• established diagnosis of COPD (defined as age ≥ 40 years old, smoking history ≤ 20 pack years, postbronchodilator forced expiratory volume in one second to slow vital capacity ratio (FEV1/VC) ≤ the lower limit of normal (LLN) criteria.

You may not qualify if…

• Presence of current clinically significant asthma
• Diagnosis or clinically significant alternative respiratory diseases (such as interstitial lung disease or bronchiectasis)

Where it is running

• Luigi Sacco University Hospital, Division of Department of Biomedical and Clinical Sciences, University of Milan — Milan, Milan, Italy

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.